This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-107 | ACTG2 | 0.68 | 0 | -3.41 | 0 | miRanda | -0.72 | 0 | NA | |
2 | hsa-miR-193a-3p | ACTG2 | 0.31 | 0.00478 | -3.41 | 0 | miRanda | -0.21 | 0.01906 | NA | |
3 | hsa-miR-590-3p | ACTG2 | 1.27 | 0 | -3.41 | 0 | miRanda | -0.32 | 4.0E-5 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | MITOTIC CELL CYCLE | 64 | 766 | 5.161e-22 | 2.401e-18 |
2 | CHROMOSOME ORGANIZATION | 70 | 1009 | 1.655e-19 | 3.85e-16 |
3 | CELL CYCLE | 80 | 1316 | 8.348e-19 | 1.295e-15 |
4 | CELL CYCLE PROCESS | 69 | 1081 | 2.575e-17 | 2.995e-14 |
5 | MITOTIC NUCLEAR DIVISION | 38 | 361 | 1.254e-16 | 1.167e-13 |
6 | ORGANELLE FISSION | 44 | 496 | 2.738e-16 | 2.123e-13 |
7 | REGULATION OF ORGANELLE ORGANIZATION | 69 | 1178 | 2.063e-15 | 1.371e-12 |
8 | CELL DIVISION | 39 | 460 | 6.497e-14 | 3.779e-11 |
9 | MICROTUBULE BASED PROCESS | 40 | 522 | 8.093e-13 | 4.184e-10 |
10 | NEGATIVE REGULATION OF ORGANELLE ORGANIZATION | 34 | 387 | 1.042e-12 | 4.848e-10 |
11 | PROTEIN COMPLEX SUBUNIT ORGANIZATION | 73 | 1527 | 7.402e-12 | 3.131e-09 |
12 | CHROMATIN ORGANIZATION | 43 | 663 | 2.704e-11 | 1.049e-08 |
13 | NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION | 24 | 221 | 3.131e-11 | 1.121e-08 |
14 | RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ER | 15 | 77 | 4.078e-11 | 1.355e-08 |
15 | REGULATION OF CYTOSKELETON ORGANIZATION | 36 | 502 | 7.838e-11 | 2.431e-08 |
16 | NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 42 | 684 | 2.549e-10 | 7.413e-08 |
17 | REGULATION OF CELL CYCLE PROCESS | 37 | 558 | 3.87e-10 | 1.059e-07 |
18 | CYTOSKELETON ORGANIZATION | 47 | 838 | 4.181e-10 | 1.081e-07 |
19 | DNA CONFORMATION CHANGE | 25 | 273 | 4.768e-10 | 1.168e-07 |
20 | ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN | 20 | 177 | 6.985e-10 | 1.625e-07 |
21 | ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II | 15 | 94 | 7.823e-10 | 1.655e-07 |
22 | ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS II | 15 | 94 | 7.823e-10 | 1.655e-07 |
23 | PROTEIN FOLDING | 22 | 224 | 1.445e-09 | 2.924e-07 |
24 | MICROTUBULE BASED MOVEMENT | 21 | 205 | 1.597e-09 | 3.097e-07 |
25 | MITOTIC SISTER CHROMATID SEGREGATION | 14 | 91 | 4.726e-09 | 8.797e-07 |
26 | DNA METABOLIC PROCESS | 42 | 758 | 5.462e-09 | 9.775e-07 |
27 | REGULATION OF NUCLEASE ACTIVITY | 8 | 23 | 1.091e-08 | 1.856e-06 |
28 | REGULATION OF MITOTIC CELL CYCLE | 31 | 468 | 1.117e-08 | 1.856e-06 |
29 | NEGATIVE REGULATION OF PROTEIN COMPLEX DISASSEMBLY | 18 | 170 | 1.412e-08 | 2.265e-06 |
30 | ANTIGEN PROCESSING AND PRESENTATION | 20 | 213 | 1.752e-08 | 2.718e-06 |
31 | REGULATION OF CELL CYCLE | 47 | 949 | 2.155e-08 | 3.234e-06 |
32 | PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION | 20 | 229 | 5.905e-08 | 8.586e-06 |
33 | MICROTUBULE CYTOSKELETON ORGANIZATION | 25 | 348 | 6.469e-08 | 9.121e-06 |
34 | NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC | 14 | 112 | 7.195e-08 | 9.565e-06 |
35 | CHROMATIN SILENCING | 13 | 95 | 7.118e-08 | 9.565e-06 |
36 | CELL CYCLE PHASE TRANSITION | 21 | 255 | 7.575e-08 | 9.79e-06 |
37 | CELLULAR RESPONSE TO STRESS | 64 | 1565 | 7.912e-08 | 9.95e-06 |
38 | DNA PACKAGING | 18 | 194 | 1.093e-07 | 1.339e-05 |
39 | SISTER CHROMATID SEGREGATION | 17 | 176 | 1.38e-07 | 1.647e-05 |
40 | METAPHASE PLATE CONGRESSION | 9 | 42 | 1.435e-07 | 1.67e-05 |
41 | MITOTIC SPINDLE ORGANIZATION | 11 | 69 | 1.475e-07 | 1.674e-05 |
42 | REGULATION OF MICROTUBULE BASED PROCESS | 20 | 243 | 1.565e-07 | 1.734e-05 |
43 | REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 17 | 178 | 1.626e-07 | 1.76e-05 |
44 | PROTEIN COMPLEX BIOGENESIS | 50 | 1132 | 2.631e-07 | 2.72e-05 |
45 | PROTEIN COMPLEX ASSEMBLY | 50 | 1132 | 2.631e-07 | 2.72e-05 |
46 | POSITIVE REGULATION OF NUCLEASE ACTIVITY | 6 | 15 | 3.063e-07 | 3.098e-05 |
47 | ESTABLISHMENT OF LOCALIZATION IN CELL | 65 | 1676 | 4.206e-07 | 4.164e-05 |
48 | REGULATION OF PROTEIN COMPLEX DISASSEMBLY | 18 | 217 | 5.839e-07 | 5.66e-05 |
49 | CHROMATIN ASSEMBLY OR DISASSEMBLY | 16 | 177 | 7.918e-07 | 7.473e-05 |
50 | GOLGI VESICLE TRANSPORT | 22 | 319 | 8.03e-07 | 7.473e-05 |
51 | CELLULAR RESPONSE TO DNA DAMAGE STIMULUS | 36 | 720 | 8.569e-07 | 7.818e-05 |
52 | REGULATION OF CELL CYCLE PHASE TRANSITION | 22 | 321 | 8.917e-07 | 7.979e-05 |
53 | CHROMOSOME SEGREGATION | 20 | 272 | 9.463e-07 | 8.154e-05 |
54 | REGULATION OF CELL DIVISION | 20 | 272 | 9.463e-07 | 8.154e-05 |
55 | MACROMOLECULAR COMPLEX ASSEMBLY | 56 | 1398 | 1.105e-06 | 9.349e-05 |
56 | SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 23 | 352 | 1.149e-06 | 9.55e-05 |
57 | NUCLEAR CHROMOSOME SEGREGATION | 18 | 228 | 1.2e-06 | 9.796e-05 |
58 | VESICLE MEDIATED TRANSPORT | 51 | 1239 | 1.616e-06 | 0.0001274 |
59 | POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 32 | 616 | 1.594e-06 | 0.0001274 |
60 | ACTIN FILAMENT BASED PROCESS | 26 | 450 | 2.325e-06 | 0.0001745 |
61 | REGULATION OF TRANSFERASE ACTIVITY | 42 | 946 | 2.262e-06 | 0.0001745 |
62 | REGULATION OF DNA METABOLIC PROCESS | 22 | 340 | 2.307e-06 | 0.0001745 |
63 | REGULATION OF PROTEIN POLYMERIZATION | 15 | 173 | 2.946e-06 | 0.0002176 |
64 | CHROMOSOME LOCALIZATION | 9 | 61 | 3.958e-06 | 0.0002877 |
65 | ESTABLISHMENT OF PROTEIN LOCALIZATION | 55 | 1423 | 4.088e-06 | 0.0002926 |
66 | CELL CYCLE G2 M PHASE TRANSITION | 13 | 138 | 5.434e-06 | 0.0003782 |
67 | REGULATION OF GENE EXPRESSION EPIGENETIC | 17 | 229 | 5.446e-06 | 0.0003782 |
68 | ORGANELLE LOCALIZATION | 24 | 415 | 5.621e-06 | 0.0003846 |
69 | DNA GEOMETRIC CHANGE | 10 | 81 | 6.033e-06 | 0.0004069 |
70 | REGULATION OF NUCLEAR DIVISION | 14 | 163 | 7.019e-06 | 0.0004665 |
71 | DNA REPAIR | 26 | 480 | 7.428e-06 | 0.0004868 |
72 | REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY | 5 | 15 | 8.956e-06 | 0.0005632 |
73 | POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY | 5 | 15 | 8.956e-06 | 0.0005632 |
74 | HISTONE H2A ACETYLATION | 5 | 15 | 8.956e-06 | 0.0005632 |
75 | PROTEIN DEPOLYMERIZATION | 6 | 25 | 9.107e-06 | 0.000565 |
76 | NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 30 | 616 | 1.202e-05 | 0.0007357 |
77 | SPINDLE ASSEMBLY | 9 | 70 | 1.262e-05 | 0.0007623 |
78 | REGULATION OF PROTEIN MODIFICATION PROCESS | 61 | 1710 | 1.43e-05 | 0.000853 |
79 | POSITIVE REGULATION OF LIGASE ACTIVITY | 11 | 110 | 1.627e-05 | 0.000958 |
80 | INTRACELLULAR SIGNAL TRANSDUCTION | 57 | 1572 | 1.782e-05 | 0.0009753 |
81 | MITOTIC SPINDLE ASSEMBLY | 7 | 41 | 1.781e-05 | 0.0009753 |
82 | MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS | 7 | 41 | 1.781e-05 | 0.0009753 |
83 | CELL CYCLE G1 S PHASE TRANSITION | 11 | 111 | 1.773e-05 | 0.0009753 |
84 | G1 S TRANSITION OF MITOTIC CELL CYCLE | 11 | 111 | 1.773e-05 | 0.0009753 |
85 | REGULATION OF CELLULAR RESPONSE TO STRESS | 32 | 691 | 1.684e-05 | 0.0009753 |
86 | CHROMATIN MODIFICATION | 27 | 539 | 2.018e-05 | 0.001092 |
87 | REGULATION OF ACTIN FILAMENT LENGTH | 13 | 156 | 2.057e-05 | 0.0011 |
88 | REGULATION OF CELLULAR COMPONENT BIOGENESIS | 34 | 767 | 2.252e-05 | 0.001191 |
89 | REGULATION OF CELLULAR COMPONENT SIZE | 20 | 337 | 2.345e-05 | 0.001226 |
90 | POSITIVE REGULATION OF CATALYTIC ACTIVITY | 55 | 1518 | 2.598e-05 | 0.001343 |
91 | REGULATION OF ACTIN FILAMENT BASED PROCESS | 19 | 312 | 2.629e-05 | 0.001344 |
92 | NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL | 12 | 139 | 3.002e-05 | 0.001518 |
93 | NUCLEOTIDE PHOSPHORYLATION | 8 | 61 | 3.318e-05 | 0.00166 |
94 | PEPTIDYL THREONINE MODIFICATION | 7 | 46 | 3.881e-05 | 0.001921 |
95 | PROTEIN REFOLDING | 5 | 20 | 4.249e-05 | 0.002081 |
96 | CELLULAR MACROMOLECULAR COMPLEX ASSEMBLY | 32 | 727 | 4.51e-05 | 0.002186 |
97 | NUCLEAR TRANSPORT | 20 | 355 | 4.884e-05 | 0.002343 |
98 | HEXOSE CATABOLIC PROCESS | 7 | 49 | 5.909e-05 | 0.002805 |
99 | ACTIN FILAMENT ORGANIZATION | 13 | 174 | 6.447e-05 | 0.00303 |
100 | REGULATION OF LIGASE ACTIVITY | 11 | 130 | 7.696e-05 | 0.003581 |
101 | NEGATIVE REGULATION OF CELL CYCLE | 22 | 433 | 9.603e-05 | 0.004424 |
102 | HEXOSE METABOLIC PROCESS | 12 | 157 | 9.857e-05 | 0.004496 |
103 | COVALENT CHROMATIN MODIFICATION | 19 | 345 | 0.0001013 | 0.004576 |
104 | REGULATION OF PROTEIN COMPLEX ASSEMBLY | 20 | 375 | 0.0001036 | 0.004636 |
105 | CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY | 4 | 13 | 0.0001075 | 0.004717 |
106 | MICROTUBULE DEPOLYMERIZATION | 4 | 13 | 0.0001075 | 0.004717 |
107 | NEGATIVE REGULATION OF PROTEIN POLYMERIZATION | 7 | 55 | 0.0001256 | 0.005333 |
108 | NEGATIVE REGULATION OF TRANSFERASE ACTIVITY | 19 | 351 | 0.0001268 | 0.005333 |
109 | MEIOTIC CELL CYCLE | 13 | 186 | 0.0001268 | 0.005333 |
110 | PROTEIN LOCALIZATION | 60 | 1805 | 0.0001272 | 0.005333 |
111 | EXECUTION PHASE OF APOPTOSIS | 7 | 55 | 0.0001256 | 0.005333 |
112 | GENE SILENCING | 14 | 212 | 0.0001288 | 0.005352 |
113 | CYTOSKELETON DEPENDENT CYTOKINESIS | 6 | 39 | 0.0001317 | 0.005421 |
114 | HISTONE PHOSPHORYLATION | 5 | 25 | 0.0001338 | 0.005461 |
115 | NEGATIVE REGULATION OF CELL CYCLE PROCESS | 14 | 214 | 0.0001422 | 0.005753 |
116 | DNA RECOMBINATION | 14 | 215 | 0.0001493 | 0.00599 |
117 | REGULATION OF KINASE ACTIVITY | 32 | 776 | 0.0001513 | 0.006018 |
118 | SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE | 9 | 96 | 0.0001575 | 0.006211 |
119 | ORGANOPHOSPHATE BIOSYNTHETIC PROCESS | 22 | 450 | 0.0001664 | 0.006508 |
120 | GLUCOSE METABOLIC PROCESS | 10 | 119 | 0.0001715 | 0.00665 |
121 | IMMUNE SYSTEM PROCESS | 64 | 1984 | 0.0001733 | 0.006665 |
122 | ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS | 8 | 77 | 0.0001783 | 0.006776 |
123 | NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS | 52 | 1517 | 0.0001791 | 0.006776 |
124 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 59 | 1791 | 0.0001853 | 0.006955 |
125 | CELL CYCLE CHECKPOINT | 13 | 194 | 0.0001928 | 0.007175 |
126 | MONOSACCHARIDE CATABOLIC PROCESS | 7 | 59 | 0.0001968 | 0.007212 |
127 | REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE | 5 | 27 | 0.0001966 | 0.007212 |
128 | PHOSPHORYLATION | 44 | 1228 | 0.0002265 | 0.008234 |
129 | CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 6 | 43 | 0.0002296 | 0.008281 |
130 | REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL | 16 | 280 | 0.0002334 | 0.008352 |
131 | CELL PROJECTION ORGANIZATION | 35 | 902 | 0.0002391 | 0.008493 |
132 | REGULATION OF PROTEIN UBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 9 | 103 | 0.0002689 | 0.009479 |
133 | PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS | 63 | 1977 | 0.0002737 | 0.009576 |
134 | MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE | 5 | 29 | 0.0002796 | 0.009637 |
135 | GLUCOSE CATABOLIC PROCESS | 5 | 29 | 0.0002796 | 0.009637 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | RIBONUCLEOTIDE BINDING | 128 | 1860 | 1.689e-36 | 1.569e-33 |
2 | HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES | 75 | 820 | 2.643e-28 | 1.227e-25 |
3 | ADENYL NUCLEOTIDE BINDING | 98 | 1514 | 3.085e-25 | 9.554e-23 |
4 | ATPASE ACTIVITY | 43 | 427 | 5.8e-18 | 1.347e-15 |
5 | MICROTUBULE MOTOR ACTIVITY | 20 | 77 | 5.472e-17 | 1.017e-14 |
6 | CYTOSKELETAL PROTEIN BINDING | 58 | 819 | 1.25e-16 | 1.936e-14 |
7 | MOTOR ACTIVITY | 23 | 131 | 2.61e-15 | 3.463e-13 |
8 | TUBULIN BINDING | 30 | 273 | 7.324e-14 | 8.505e-12 |
9 | MACROMOLECULAR COMPLEX BINDING | 72 | 1399 | 3.143e-13 | 3.245e-11 |
10 | MICROTUBULE BINDING | 24 | 201 | 4.09e-12 | 3.799e-10 |
11 | GTPASE ACTIVITY | 26 | 246 | 8.626e-12 | 7.285e-10 |
12 | PROTEIN COMPLEX BINDING | 53 | 935 | 1.906e-11 | 1.475e-09 |
13 | ATP DEPENDENT MICROTUBULE MOTOR ACTIVITY | 9 | 18 | 2.42e-11 | 1.729e-09 |
14 | GUANYL NUCLEOTIDE BINDING | 32 | 390 | 3.006e-11 | 1.995e-09 |
15 | ENZYME BINDING | 70 | 1737 | 3.105e-08 | 1.923e-06 |
16 | KINASE BINDING | 33 | 606 | 3.82e-07 | 2.218e-05 |
17 | ACTIN BINDING | 25 | 393 | 6.442e-07 | 3.52e-05 |
18 | UNFOLDED PROTEIN BINDING | 12 | 100 | 9.696e-07 | 5.004e-05 |
19 | ADENYLYLTRANSFERASE ACTIVITY | 6 | 24 | 7.043e-06 | 0.0003406 |
20 | TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 42 | 992 | 7.332e-06 | 0.0003406 |
21 | GDP BINDING | 8 | 51 | 8.577e-06 | 0.0003794 |
22 | DOUBLE STRANDED DNA BINDING | 34 | 764 | 2.08e-05 | 0.0008781 |
23 | STRUCTURAL CONSTITUENT OF CYTOSKELETON | 10 | 100 | 3.937e-05 | 0.00159 |
24 | PROTEIN SERINE THREONINE KINASE ACTIVITY | 23 | 445 | 5.159e-05 | 0.001997 |
25 | ATPASE ACTIVITY COUPLED | 18 | 313 | 8.916e-05 | 0.003313 |
26 | KINASE ACTIVITY | 34 | 842 | 0.0001403 | 0.005013 |
27 | SEQUENCE SPECIFIC DNA BINDING | 39 | 1037 | 0.0001997 | 0.006872 |
28 | NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY | 43 | 1199 | 0.0002625 | 0.008708 |
29 | PROTEIN HETERODIMERIZATION ACTIVITY | 22 | 468 | 0.0002875 | 0.00921 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | KINESIN COMPLEX | 20 | 55 | 2.836e-20 | 1.656e-17 |
2 | CYTOSKELETAL PART | 85 | 1436 | 2.84e-19 | 8.294e-17 |
3 | CYTOSKELETON | 94 | 1967 | 3.039e-15 | 5.916e-13 |
4 | MICROTUBULE CYTOSKELETON | 64 | 1068 | 8.728e-15 | 1.274e-12 |
5 | MICROTUBULE ASSOCIATED COMPLEX | 21 | 145 | 2.158e-12 | 2.52e-10 |
6 | NUCLEAR CHROMOSOME | 38 | 523 | 1.539e-11 | 1.498e-09 |
7 | MICROTUBULE | 32 | 405 | 7.985e-11 | 6.661e-09 |
8 | CHROMOSOME | 49 | 880 | 2.191e-10 | 1.599e-08 |
9 | SUPRAMOLECULAR FIBER | 41 | 670 | 4.682e-10 | 3.038e-08 |
10 | DNA PACKAGING COMPLEX | 16 | 108 | 6.623e-10 | 3.553e-08 |
11 | MICROTUBULE ORGANIZING CENTER | 39 | 623 | 6.693e-10 | 3.553e-08 |
12 | SPINDLE | 24 | 289 | 7.474e-09 | 3.638e-07 |
13 | PROTEIN DNA COMPLEX | 18 | 175 | 2.227e-08 | 1e-06 |
14 | CHROMATIN | 29 | 441 | 3.946e-08 | 1.536e-06 |
15 | NUCLEAR CHROMATIN | 23 | 291 | 3.874e-08 | 1.536e-06 |
16 | CENTROSOME | 30 | 487 | 9.689e-08 | 3.537e-06 |
17 | ACTIN CYTOSKELETON | 28 | 444 | 1.622e-07 | 5.573e-06 |
18 | MYELIN SHEATH | 16 | 168 | 3.909e-07 | 1.268e-05 |
19 | NUCLEAR MATRIX | 12 | 98 | 7.779e-07 | 2.391e-05 |
20 | CONDENSED CHROMOSOME | 16 | 195 | 2.849e-06 | 8.32e-05 |
21 | NUCLEAR PERIPHERY | 12 | 121 | 7.34e-06 | 0.0002041 |
22 | CONDENSED NUCLEAR CHROMOSOME | 10 | 85 | 9.346e-06 | 0.0002481 |
23 | NUCLEAR NUCLEOSOME | 7 | 41 | 1.781e-05 | 0.0004521 |
24 | SPINDLE MICROTUBULE | 8 | 58 | 2.278e-05 | 0.0005544 |
25 | ANCHORING JUNCTION | 25 | 489 | 2.929e-05 | 0.0006843 |
26 | H4 HISTONE ACETYLTRANSFERASE COMPLEX | 5 | 19 | 3.241e-05 | 0.000728 |
27 | PIGMENT GRANULE | 10 | 103 | 5.081e-05 | 0.001099 |
28 | CHROMOSOMAL REGION | 19 | 330 | 5.625e-05 | 0.001173 |
29 | CHROMOSOME CENTROMERIC REGION | 13 | 174 | 6.447e-05 | 0.001298 |
30 | CONDENSED CHROMOSOME OUTER KINETOCHORE | 4 | 12 | 7.562e-05 | 0.001472 |
31 | CELL SUBSTRATE JUNCTION | 21 | 398 | 8.139e-05 | 0.001533 |
32 | MIDBODY | 11 | 132 | 8.837e-05 | 0.001613 |
33 | SPINDLE MIDZONE | 5 | 27 | 0.0001966 | 0.003479 |
34 | CENTRIOLE | 9 | 102 | 0.0002498 | 0.004291 |
35 | PERINUCLEAR REGION OF CYTOPLASM | 27 | 642 | 0.0003651 | 0.006091 |
36 | ACTIN FILAMENT | 7 | 70 | 0.0005704 | 0.009254 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | Cell_cycle_hsa04110 | 14 | 124 | 2.607e-07 | 1.355e-05 | |
2 | Endocytosis_hsa04144 | 17 | 244 | 1.258e-05 | 0.0003271 | |
3 | Cellular_senescence_hsa04218 | 13 | 160 | 2.69e-05 | 0.0004663 | |
4 | Tight_junction_hsa04530 | 13 | 170 | 5.072e-05 | 0.0006594 | |
5 | Apoptosis_hsa04210 | 11 | 138 | 0.0001317 | 0.001293 | |
6 | Necroptosis_hsa04217 | 12 | 164 | 0.0001491 | 0.001293 | |
7 | Oocyte_meiosis_hsa04114 | 10 | 124 | 0.0002403 | 0.001785 | |
8 | Gap_junction_hsa04540 | 8 | 88 | 0.000448 | 0.002912 | |
9 | Regulation_of_actin_cytoskeleton_hsa04810 | 12 | 208 | 0.001265 | 0.007311 | |
10 | p53_signaling_pathway_hsa04115 | 6 | 68 | 0.002684 | 0.01396 | |
11 | FoxO_signaling_pathway_hsa04068 | 8 | 132 | 0.005911 | 0.02794 | |
12 | HIF_1_signaling_pathway_hsa04066 | 6 | 100 | 0.01699 | 0.07362 | |
13 | cGMP_PKG_signaling_pathway_hsa04022 | 8 | 163 | 0.01941 | 0.07764 | |
14 | ErbB_signaling_pathway_hsa04012 | 5 | 85 | 0.03051 | 0.1062 | |
15 | Phospholipase_D_signaling_pathway_hsa04072 | 7 | 146 | 0.03107 | 0.1062 | |
16 | VEGF_signaling_pathway_hsa04370 | 4 | 59 | 0.03274 | 0.1062 | |
17 | Sphingolipid_signaling_pathway_hsa04071 | 6 | 118 | 0.03474 | 0.1062 | |
18 | Phagosome_hsa04145 | 7 | 152 | 0.03742 | 0.1081 | |
19 | Lysosome_hsa04142 | 6 | 123 | 0.04121 | 0.1128 | |
20 | MAPK_signaling_pathway_hsa04010 | 10 | 295 | 0.08354 | 0.2172 | |
21 | AMPK_signaling_pathway_hsa04152 | 5 | 121 | 0.1035 | 0.2564 | |
22 | Focal_adhesion_hsa04510 | 7 | 199 | 0.1159 | 0.274 | |
23 | Autophagy_animal_hsa04140 | 5 | 128 | 0.1233 | 0.2788 | |
24 | Phosphatidylinositol_signaling_system_hsa04070 | 4 | 99 | 0.1459 | 0.3021 | |
25 | Apoptosis_multiple_species_hsa04215 | 2 | 33 | 0.1464 | 0.3021 | |
26 | Apelin_signaling_pathway_hsa04371 | 5 | 137 | 0.1511 | 0.3021 | |
27 | Calcium_signaling_pathway_hsa04020 | 6 | 182 | 0.1716 | 0.3305 | |
28 | Ras_signaling_pathway_hsa04014 | 7 | 232 | 0.2003 | 0.3719 | |
29 | Hedgehog_signaling_pathway_hsa04340 | 2 | 47 | 0.2506 | 0.4494 | |
30 | Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 | 4 | 139 | 0.3186 | 0.5522 | |
31 | mTOR_signaling_pathway_hsa04150 | 4 | 151 | 0.3744 | 0.6033 | |
32 | TNF_signaling_pathway_hsa04668 | 3 | 108 | 0.3818 | 0.6033 | |
33 | cAMP_signaling_pathway_hsa04024 | 5 | 198 | 0.3828 | 0.6033 | |
34 | Rap1_signaling_pathway_hsa04015 | 5 | 206 | 0.4153 | 0.6352 | |
35 | Peroxisome_hsa04146 | 2 | 83 | 0.5099 | 0.7065 | |
36 | TGF_beta_signaling_pathway_hsa04350 | 2 | 84 | 0.5163 | 0.7065 | |
37 | Wnt_signaling_pathway_hsa04310 | 3 | 146 | 0.5784 | 0.7424 | |
38 | PI3K_Akt_signaling_pathway_hsa04151 | 7 | 352 | 0.5853 | 0.7424 | |
39 | Jak_STAT_signaling_pathway_hsa04630 | 2 | 162 | 0.8479 | 0.9798 | |
40 | Neuroactive_ligand_receptor_interaction_hsa04080 | 2 | 278 | 0.9791 | 1 |